Ten-Year Outcomes of PRE-COMBAT Trial
PRECOMBAT
Ten-Year Outcomes of PREmier of Randomized Comparison of Sirolimus-Eluting Stent Implantation Versus Coronary Artery Bypass Surgery for Unprotected Left Main Coronary Artery Stenosis: PRE-COMBAT Trial
1 other identifier
observational
600
1 country
9
Brief Summary
This study evaluates Ten-Year Outcomes of PREmier of Randomized Comparison of Sirolimus-Eluting Stent Implantation Versus Coronary Artery Bypass Surgery for Unprotected Left Main Coronary Artery Stenosis(PRECOMBAT trial).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started May 2019
Shorter than P25 for all trials
9 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 7, 2019
CompletedFirst Posted
Study publicly available on registry
March 12, 2019
CompletedStudy Start
First participant enrolled
May 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 24, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 24, 2020
CompletedJune 18, 2020
June 1, 2020
10 months
March 7, 2019
June 18, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Composite outcome
The composite of death, myocardial infarction, and revascularization. Patients who have experienced any one of the following events are considered to have experienced the composite outcome: death, myocardial infarction, and revascularization
10 year
Secondary Outcomes (10)
All-cause mortality
10 year
Cardiac death
10 year
Myocardial infarction
10 year
Cerebrovascular accident
10 year
Target vessel revascularization
10 year
- +5 more secondary outcomes
Study Arms (1)
Left main coronary disease
Interventions
Eligibility Criteria
Subject group enrolled in PRECOMBAT trial
You may qualify if:
- Subject group enrolled in PRECOMBAT trial
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Seung-Jung Parklead
- CardioVascular Research Foundation, Koreacollaborator
Study Sites (9)
Chonnam National University Hospital
Gwangju, South Korea
Seoul National University Bundang hospital
Seongnam, South Korea
Asan Medical Center
Seoul, South Korea
Korea University Anam Hospital
Seoul, South Korea
Korea University Guro Hospital
Seoul, South Korea
Samsung Medical Center
Seoul, South Korea
Seoul National University Hospital
Seoul, South Korea
Ajou University Hospital
Suwon, South Korea
Ulsan University Hospital
Ulsan, South Korea
Related Publications (4)
Yang Y, Jeong YJ, Hyun J, Lee J, Kim JH, Kim S, Kang DY, Lee PH, Ahn JM, Park DW, Park SJ; PRECOMBAT Investigators. Prognostic Value of Sex After Revascularization for Left Main Coronary Disease: Extended PRECOMBAT Study. JACC Asia. 2021 Nov 9;2(1):19-29. doi: 10.1016/j.jacasi.2021.08.009. eCollection 2022 Feb.
PMID: 36340254DERIVEDJeong YJ, Ahn JM, Hyun J, Lee J, Kim JH, Yang Y, Choe K, Park H, Kang DY, Lee PH, Kang SJ, Lee SW, Kim YH, Lee CW, Park SW, Park SJ, Park DW. Ten-year Outcomes After Drug-Eluting Stents or Bypass Surgery for Left Main Coronary Disease in Patients With and Without Diabetes Mellitus: The PRECOMBAT Extended Follow-Up Study. J Am Heart Assoc. 2021 Jul 20;10(14):e019834. doi: 10.1161/JAHA.120.019834. Epub 2021 Jul 9.
PMID: 34238026DERIVEDLee J, Ahn JM, Kim JH, Jeong YJ, Hyun J, Yang Y, Lee JS, Park H, Kang DY, Lee PH, Park DW, Park SJ; on the behalf of the PRECOMBAT Investigators. Prognostic Effect of the SYNTAX Score on 10-Year Outcomes After Left Main Coronary Artery Revascularization in a Randomized Population: Insights From the Extended PRECOMBAT Trial. J Am Heart Assoc. 2021 Jul 20;10(14):e020359. doi: 10.1161/JAHA.120.020359. Epub 2021 Jul 6.
PMID: 34227392DERIVEDPark DW, Ahn JM, Park H, Yun SC, Kang DY, Lee PH, Kim YH, Lim DS, Rha SW, Park GM, Gwon HC, Kim HS, Chae IH, Jang Y, Jeong MH, Tahk SJ, Seung KB, Park SJ; PRECOMBAT Investigators. Ten-Year Outcomes After Drug-Eluting Stents Versus Coronary Artery Bypass Grafting for Left Main Coronary Disease: Extended Follow-Up of the PRECOMBAT Trial. Circulation. 2020 May 5;141(18):1437-1446. doi: 10.1161/CIRCULATIONAHA.120.046039. Epub 2020 Mar 30.
PMID: 32223567DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Professor, Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine
Study Record Dates
First Submitted
March 7, 2019
First Posted
March 12, 2019
Study Start
May 1, 2019
Primary Completion
February 24, 2020
Study Completion
February 24, 2020
Last Updated
June 18, 2020
Record last verified: 2020-06